Topics:

HPV

HPV

The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.

The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.

The American College of Physicians (ACP) recommends against pelvic exams in asymptomatic, nonpregnant, adult women. Some say this is faulty logic. What say you?

Don’t let time constraints and large patient loads prevent you from providing a thorough well-woman visit. Are you covering all the bases?

An FDA panel has recommended that a DNA test that screens for HPV in women can replace the standard Pap smear as a first-line primary cervical cancer screening test.

Why the USPSTF has declined to recommend regular screening for oral cancer in primary care, and a new biomarker for metastasis in oral squamous cell carcinoma.

Female providers were twice as likely as their male counterparts to order HPV testing for low-risk women aged 30 to 65 who had normal Pap smear results.

Pages

Subscribe to HPV on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.